Search Results for 'Phase III'
Contract Service Directory Companies
Microsite Companies
Featured Companies
View All Buyers Guide Companies »
Contract Service Directory Categories
View All Categories »
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News
Moderna Completes Enrollment in Phase III COVID-19 Vax Study
COVE study designed in collaboration with the FDA and NIH to evaluate Americans at the highest risk of severe COVID-19 disease in 30,000 participants.Contract Pharma Staff 10.22.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News
J&J Initiates Phase III ENSEMBLE Trial for COVID-19 Vax
Will enroll up to 60,000 volunteers across three continents to study the safety and efficacy of a single vaccine dose of JNJ-78436735 versus placebo.Contract Pharma Staff 09.23.20
-
Breaking News | Clinical Trials | Industry News
Roche’s Phase III Trial of Actemra in COVID-19 Misses Primary Endpoint
COVACTA trial did not meet primary endpoint of improved clinical status in patients with COVID-19 associated pneumonia, or the key secondary endpoints.Contract Pharma Staff 07.30.20
-
Clinical Trials | CRO News | Trials & Filings
Lipidor, Cadila Sign Agreement for Phase III Trial of AKP-02
Cadila Pharmaceuticals to conduct a Phase III study for Lipidor's anti-psoriasis candidate AKP-02.Contract Pharma Staff 07.07.20
-
Breaking News | Clinical Trials | Drug Development | Trials & Filings
Roche Initiates Phase III Trial in COVID-19 Pneumonia
To evaluate Actemra/RoActemra plus remdesivir in hospitalized patients with severe Pneumonia.Contract Pharma Staff 05.28.20
-
Breaking News | Drug Development | Industry News
Roche Accelerates Phase III Actemra Trial in COVID-19
Receives $25 million in support from BARDA to evaluate safety and efficacy in severe COVID-19 pneumoniaContract Pharma Staff 04.08.20
-
Gilead Initiates Phase III Studies of Remdesivir in COVID-19
Studies follow the U.S. FDA rapid review and acceptance of Gilead’s investigational new drug filing for remdesivir for the treatment of COVID-1903.04.20
-
Bio News | Clinical Trials | Industry News | R&D
Roche Phase III Study Meets Primary Objective
Assessing the safety and efficacy of baloxavir marboxil in people at high risk of complications from the flu07.17.18
